COVID-19 Archives – Cambridge Enterprise

Cambridge spin-out enters $42m partnership to develop ‘future-proofed’ coronavirus vaccines

Closeup shot of a male patient receiving an injection from a doctor

DIOSynVax: Tackling COVID-19

Cambridge spin-out Sano Genetics raises £2.5m and accelerates research into long COVID

29 January 2021

Coronavirus (COVID) abstract image

Top US, UK, and EU universities work together to help economies fuel post-COVID recovery

18 September 2020

Getting down to business: entrepreneurship in tough times

15 September 2020

Coronavirus

Rising interest in virus research tools

Pipettes

Intellectual property and COVID-19

Nurse using SAMBA machines

Rapid COVID-19 diagnostic test developed by Cambridge spin-out to be deployed in hospitals

Coronavirus

DIOSynVax works towards vaccine against COVID-19